Do the risks of extracorporeal membrane oxygenation in cardiogenic shock outweigh the potential benefits?
Eur Heart J Acute Cardiovasc Care
.
2024 Feb 16;13(2):213-214.
doi: 10.1093/ehjacc/zuad159.
Authors
Bram J Geller
1
2
,
Sean van Diepen
3
4
Affiliations
1
Department of Cardiovascular Medicine, Maine Medical Center, Portland, ME, USA.
2
Department of Cardiovascular Critical Care, Maine Medical Center, Portland, ME, USA.
3
Department of Critical Care Medicine, University of Alberta Hospital, Edmonton, AB, Canada.
4
Division of Cardiology, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada.
PMID:
38157414
DOI:
10.1093/ehjacc/zuad159
No abstract available
MeSH terms
Extracorporeal Membrane Oxygenation* / adverse effects
Humans
Shock, Cardiogenic* / therapy
Time Factors